These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12438437)

  • 1. IFN-gamma suspends the killing license of anti-tumor CTLs.
    Lukacher AE
    J Clin Invest; 2002 Nov; 110(10):1407-9. PubMed ID: 12438437
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor viral escape from inhibited T cells.
    Welsh RM; Stepp SE; Szomolanyi-Tsuda E; Peacock CD
    Nat Immunol; 2002 Feb; 3(2):112-4. PubMed ID: 11812984
    [No Abstract]   [Full Text] [Related]  

  • 3. Signal sequences stop killer cells.
    Long EO
    Nature; 1998 Feb; 391(6669):740-1, 743. PubMed ID: 9486638
    [No Abstract]   [Full Text] [Related]  

  • 4. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism.
    Malmberg KJ; Levitsky V; Norell H; de Matos CT; Carlsten M; Schedvins K; Rabbani H; Moretta A; Söderström K; Levitskaya J; Kiessling R
    J Clin Invest; 2002 Nov; 110(10):1515-23. PubMed ID: 12438449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CD94/NKG2A--a kind of inhibitory receptor belonging to C-type lectin superfamily].
    Wang Y; Zhu LP; Zhang W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):653-5. PubMed ID: 12905700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of natural killer cells: underlying molecular mechanisms revealed.
    Backström E; Kristensson K; Ljunggren HG
    Scand J Immunol; 2004; 60(1-2):14-22. PubMed ID: 15238069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational modeling of human natural killer cell development suggests a selection process regulating coexpression of KIR with CD94/NKG2A.
    Salmon-Divon M; Höglund P; Johansson MH; Johansson S; Mehr R
    Mol Immunol; 2005 Feb; 42(4):397-403. PubMed ID: 15607790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
    Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
    Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.
    Borrego F; Masilamani M; Kabat J; Sanni TB; Coligan JE
    Mol Immunol; 2005 Feb; 42(4):485-8. PubMed ID: 15607803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria.
    D'Ombrain MC; Hansen DS; Simpson KM; Schofield L
    Eur J Immunol; 2007 Jul; 37(7):1864-73. PubMed ID: 17557374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NK cell receptors and related ligands].
    Pan B; Chen YH; Zhu LP; He W; Zhang W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):650-2. PubMed ID: 12905699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good news, bad news for missing-self recognition by NK cells: autoimmune control but viral evasion.
    Vivier E; Romagné F
    Immunity; 2007 May; 26(5):549-51. PubMed ID: 17521583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of invariant NKT cells in pre-eclampsia.
    Miko E; Szereday L; Barakonyi A; Jarkovich A; Varga P; Szekeres-Bartho J
    Am J Reprod Immunol; 2008 Aug; 60(2):118-26. PubMed ID: 18573130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells.
    Kawamura H; Yagita H; Nisizawa T; Izumi N; Miyaji C; Vance RE; Raulet DH; Okumura K; Abo T
    Eur J Immunol; 2005 Aug; 35(8):2358-66. PubMed ID: 15997467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity.
    Le Bouteiller P; Barakonyi A; Giustiniani J; Lenfant F; Marie-Cardine A; Aguerre-Girr M; Rabot M; Hilgert I; Mami-Chouaib F; Tabiasco J; Boumsell L; Bensussan A
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16963-8. PubMed ID: 12486241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
    Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
    Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.